Does HRT Cause Breast Cancer? Understanding the Real Risk

Medically reviewed by Meg LaFerriere, APRN · Regulate Rx, Lee’s Summit, MO

For many women, breast cancer is the number one reason they hesitate about hormone therapy. That worry deserves a clear, calm answer rather than a scary headline.

What does the research show about HRT and breast cancer?

The answer depends on which hormones you take. In the Women’s Health Initiative, women with a uterus who took estrogen plus a synthetic progestin had a higher rate of breast cancer than women on placebo.

Women without a uterus who took estrogen alone did not show that increase. Long-term follow-up of that group actually found fewer breast cancer cases than placebo.

The Menopause Society’s 2022 position statement describes the added breast cancer risk with combined therapy as rare. It also notes the risk appears to rise with longer duration of use.

What’s the difference between relative and absolute risk?

Headlines often report relative risk, such as “a 25% increase.” That sounds alarming. Absolute risk tells you how many extra cases actually happen in a group of women.

When a baseline risk is low, even a meaningful relative increase adds only a small number of cases. That’s why experts describe the added risk from combined therapy as small, even though it’s real.

It also helps to compare it with other factors. Drinking alcohol regularly, gaining weight after menopause and being physically inactive are also linked to higher breast cancer risk.

Does the type of progesterone matter?

It may. Some large observational studies suggest that micronized progesterone, the bioidentical form, may be linked to less breast cancer risk than synthetic progestins, at least over the first several years of use.

These studies can’t prove cause and effect, and The Menopause Society calls for more research. Still, it’s one reason many practitioners favor micronized progesterone for women who need uterine protection. Women with a uterus need that protection, because estrogen alone can thicken the uterine lining.

Who should avoid hormone therapy because of breast cancer?

Systemic hormone therapy generally isn’t recommended if you’ve had breast cancer. Other situations call for extra care and conversation:

• A strong family history of breast or ovarian cancer
• A known BRCA mutation or other high-risk gene
• Dense breasts or a prior abnormal biopsy
• Overdue mammograms

Having one of these doesn’t automatically rule hormones out. It means the decision should be made carefully, sometimes with input from your oncologist or breast specialist. Low-dose vaginal estrogen is sometimes considered for breast cancer survivors with severe vaginal symptoms, but only in coordination with their cancer team.

How can you lower your risk while on HRT?

Step	Why it helps
Stay current on mammograms	Finds changes early
Use the lowest effective dose	Matches treatment to your symptoms
Review your plan every year	Lets you adjust as your needs change
Limit alcohol and stay active	Lowers risk factors you can control

At Regulate Rx in Lee’s Summit, Meg LaFerriere, APRN, reviews your personal and family history before recommending any hormone. Your practitioner reviews your history and labs at the start and checks in regularly through the women’s hormone program. Report any new breast lump, skin change or nipple discharge to a clinician promptly.

Frequently asked questions

Do I need a mammogram before starting HRT?

Most practitioners want your breast cancer screening to be up to date before starting systemic hormone therapy. If you’re due, schedule it before or around your first visit.

Does HRT make breast cancer harder to detect?

Hormone therapy can increase breast density in some women, which can make mammograms a bit harder to read. Let your imaging center know you’re on hormones.

If my mother had breast cancer, can I take HRT?

Possibly. A family history raises your baseline risk, but it doesn’t automatically rule out hormone therapy. Your age, her age at diagnosis, genetic testing and your symptoms all factor into the decision.

Sources: The Menopause Society 2022 Hormone Therapy Position Statement; Women’s Health Initiative (2002) and long-term follow-up; American Cancer Society; National Cancer Institute; Mayo Clinic

This article is for general education and isn’t medical advice. Treatments aren’t right for everyone, and results vary. Our practitioner reviews your health history before any treatment.